Auladell C - Search Results

1

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.

Folch J, Ettcheto M, Busquets O, Sánchez-López E, Castro-Torres RD, Verdaguer E, Manzine PR, Poor SR, García ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A. Folch J, et al. Among authors: auladell c. Pharmaceuticals (Basel). 2018 Jan 29;11(1):11. doi: 10.3390/ph11010011. Pharmaceuticals (Basel). 2018. PMID: 29382127 Free PMC article. Review.

2

Prevention of epilepsy by taurine treatments in mice experimental model.

Junyent F, Utrera J, Romero R, Pallàs M, Camins A, Duque D, Auladell C. Junyent F, et al. Among authors: auladell c. J Neurosci Res. 2009 May 1;87(6):1500-8. doi: 10.1002/jnr.21950. J Neurosci Res. 2009. PMID: 19025770

3

Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain.

Junyent F, Romero R, de Lemos L, Utrera J, Camins A, Pallàs M, Auladell C. Junyent F, et al. Among authors: auladell c. J Neurosci Res. 2010 Jan;88(1):136-42. doi: 10.1002/jnr.22192. J Neurosci Res. 2010. PMID: 19658200

4

Synthesis, uptake and release of taurine in astrocytes treated with 8-Br-cAMP.

Junyent F, Utrera J, Camins A, Pallàs M, Romero R, Auladell C. Junyent F, et al. Among authors: auladell c. Neurosci Lett. 2009 Dec 31;467(3):199-202. doi: 10.1016/j.neulet.2009.10.032. Epub 2009 Oct 13. Neurosci Lett. 2009. PMID: 19833172

5

Tau hyperphosphorylation and axonal damage induced by N,N-diethyldithiocarbamate (DEDTC) treatment along late postnatal development is followed by a rescue during adulthood.

Utrera J, Junyent F, de Lemos L, Pallàs M, Camins A, Romero R, Auladell C. Utrera J, et al. Among authors: auladell c. J Neurosci Res. 2010 Apr;88(5):1083-93. doi: 10.1002/jnr.22284. J Neurosci Res. 2010. PMID: 19908281

6

Content and traffic of taurine in hippocampal reactive astrocytes.

Junyent F, De Lemos L, Utrera J, Paco S, Aguado F, Camins A, Pallàs M, Romero R, Auladell C. Junyent F, et al. Among authors: auladell c. Hippocampus. 2011 Feb;21(2):185-97. doi: 10.1002/hipo.20739. Hippocampus. 2011. PMID: 20082296

7

Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.

de Lemos L, Junyent F, Verdaguer E, Folch J, Romero R, Pallàs M, Ferrer I, Auladell C, Camins A. de Lemos L, et al. Among authors: auladell c. J Neurochem. 2010 Sep 1;114(5):1315-22. doi: 10.1111/j.1471-4159.2010.06853.x. Epub 2010 Jun 8. J Neurochem. 2010. PMID: 20534003 Free article.

8

Microarray analysis of rat hippocampus exposed to excitotoxicity: reversal Na(+)/Ca(2+) exchanger NCX3 is overexpressed in glial cells.

Ortuño-Sahagún D, Rivera-Cervantes MC, Gudiño-Cabrera G, Junyent F, Verdaguer E, Auladell C, Pallàs M, Camins A, Beas-Zárate C. Ortuño-Sahagún D, et al. Among authors: auladell c. Hippocampus. 2012 Feb;22(2):128-40. doi: 10.1002/hipo.20869. Epub 2010 Oct 6. Hippocampus. 2012. PMID: 20928830

9

Gene expression profile in JNK3 null mice: a novel specific activation of the PI3K/AKT pathway.

Junyent F, de Lemos L, Verdaguer E, Folch J, Ferrer I, Ortuño-Sahagún D, Beas-Zárate C, Romero R, Pallàs M, Auladell C, Camins A. Junyent F, et al. Among authors: auladell c. J Neurochem. 2011 Apr;117(2):244-52. doi: 10.1111/j.1471-4159.2011.07195.x. Epub 2011 Feb 24. J Neurochem. 2011. PMID: 21255018 Free article.

10

Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.

Sureda FX, Junyent F, Verdaguer E, Auladell C, Pelegri C, Vilaplana J, Folch J, Canudas AM, Zarate CB, Pallès M, Camins A. Sureda FX, et al. Among authors: auladell c. Curr Pharm Des. 2011;17(3):230-45. doi: 10.2174/138161211795049732. Curr Pharm Des. 2011. PMID: 21348832 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page